<DOC>
	<DOCNO>NCT01607086</DOCNO>
	<brief_summary>The objective sensory analysis study determine whether volunteer observe significant difference organoleptic property lamotrigine ( 430C78 ) cherry flavour orally disintegrate tablet ( ODT ) placebo cherry flavour orally disintegrate tablet . The aim ass value placebo marketing aid , whereby physician patient may assess personal acceptability organoleptic property potential convenience prior prescription ODT formulation .</brief_summary>
	<brief_title>Compare Properties Characteristics Investigational Formulation Lamotrigine With Placebo</brief_title>
	<detailed_description />
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>A subject eligible inclusion study follow criterion apply : Healthy judge responsible physician designee . No clinically significant abnormality identify medical laboratory evaluation . A subject clinical abnormality laboratory parameter outside reference range age group may include Investigator Medical Monitor consider find introduce additional risk factor interfere study procedure . Volunteer must normal sense taste smell Nonsmokers exsmokers give smoke least 3 month . Subjects currently use oral nicotine replacement therapy recruit study . A subject eligible inclusion study follow criterion apply : Currently treat epilepsy bipolar disorder History allergic , anaphylactic , hypersensitivity idiosyncratic reaction ( ) lamotrigine drug similar type . History sensitivity follow excipients Mannitol , Crospovidone , Sucralose , Magnesium Stearate , artificial Cherry flavour , Ethylcellulose . History clinically relevant skin rash . History presence medical disorder view investigator GSK Medical Monitor make subject unsuitable study . History multiple allergy drug , chemical food , history clinically important allergy ( e.g . anaphylaxis ) one substance . Currently suffer perennial rhinitis seasonal rhinitis , cold , influenza respiratory illness . Has receive prescribe non prescribe medication ( include vitamin herbal remedy ) within 7 day prior test day opinion investigator consultation necessary GSK Medical Monitor may interfere study procedure compromise safety . Currently recently prescribe medication may affect lamotrigine include antiepileptic . Participation another sensory analysis study within 30 day precede test day . Treatment investigational drug within 30 day precede test day . Females positive hCG pregnancy test test day . Abuse alcohol define average weekly intake great 21 unit average daily intake great 3 unit men weekly intake great than14 unit average daily intake great 2 unit woman . [ NOTE : 1 unit equivalent halfpint ( 220mL ) beer 1 ( 25mL ) measure spirit 1 glass ( 125mL ) wine ] . Subjects must willing abstain alcohol 24 hour visit unit duration study . Where participation study would result donation blood blood product excess 500 mL within 56 day period . The subject positive drug/alcohol screen test day . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Lamotrigine</keyword>
	<keyword>placebo</keyword>
	<keyword>property</keyword>
	<keyword>characteristic</keyword>
</DOC>